Hexyon Market Report 2026

Hexyon Market Overview

• The Hexyon market growth in the historic period has been driven by needreduce injection burden in infants, strong government immunization programs • Market expansion is supported by expansion of birth cohort immunization coverage, growth in emerging market vaccination programs • Growth Driver: Rising Pediatric Population To Drive Growth In Hexyon Vaccine Market • Market Trend: Facility Expansion By Key Players To Strengthen Competitive Position In The Hexyon Market • Europe was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Hexyon Market?

Hexyon is a hexavalent vaccine used to protect against six diseases diphtheria, tetanus, pertussis, polio, hepatitis B, and Haemophilus influenzae type b. It is typically administered to infants and young children to provide immunity against these conditions. The vaccine is given as part of a routine immunization schedule and is known for its convenience in combining multiple vaccines into a single dose. The main types of hexyon products are hexavalent vaccines and monovalent and combination vaccines. Hexavalent vaccines are immunizations that protect against six different diseases in a single shot. It is used for pediatric immunization and catch-up vaccination and is distributed through hospitals, clinics, public health programs, and pharmacies.

What Is The Hexyon Market Growth Forecast?

The growth in the forecast period can be attributed to expansion of birth cohort immunization coverage, growth in emerging market vaccination programs, increased funding for pediatric healthcare, preference for cost effective combination vaccines, improved cold chain infrastructure. Major trends in the forecast period include growth of combination pediatric vaccines, simplification of childhood immunization schedules, rising demand for hexavalent vaccines, expansion of routine infant immunization programs, increased adoption in national vaccination policies.

Global Hexyon Market Segmentation

1) By Product Type: Hexavalent Vaccines, Monovalent And Combination Vaccines 2) By Indication: Pediatric Immunization, Catch-Up Vaccination 3) By Distribution Channel: Hospitals, Clinics, Public Health Programs, Pharmacies

What Are The Drivers Of The Hexyon Market?

The rise in the pediatric population is expected to fuel the growth of the hexyon market going forward. The pediatric population refers to individuals typically aged from birth up to 18 years, encompassing infants, children, and adolescents. The increasing pediatric population is largely due to improved healthcare, lower child mortality rates, and higher birth rates in some regions. Hexyon is required for the pediatric population to provide comprehensive protection against multiple serious infectious diseases, reducing the burden of vaccination and improving adherence by combining vaccines for diphtheria, tetanus, pertussis, hepatitis B, polio, and Hib in a single shot. For instance, in August 2025, according to The Office for National Statistics (ONS), a UK-based producer of official statistics, the total fertility rate (TFR) continued its downward trajectory, edging down from 1.42 to 1.41 children per woman between 2023 and 2024, despite a year-on-year increase in the absolute number of births in 2024. Therefore, the rise in the pediatric population is driving the growth of the hexyon industry. The rising investment in research and development is expected to propel the growth of the hexyon market going forward. Research and development are rising due to increasing demand for innovation, technological advancements, and the need to address complex global challenges in various industries. Research and development activities positively impact hexyon by enhancing its formulation, improving its efficacy, and expanding its indications, ensuring it meets evolving healthcare needs and increasing its market competitiveness. For instance, For instance, in April 2025, according to The Office for National Statistics (ONS), a UK-based producer of official statistics, the UK government’s net R&D spend increased by 8.2% year-on-year, rising from $20.0 billion (£16.1 billion) in 2022 to about $21.6 billion (£17.4 billion) in 2023. Therefore, the rising investment in research and development is driving the growth of the hexyon industry.

Key Players In The Global Hexyon Market

Major companies operating in the hexyon market are Sanofi S.A.

Global Hexyon Market Trends and Insights

The key trend in the hexyon market is focusing on facility expansion to gain a competitive edge in the industry. Facility expansion involves enhancing a business's physical space or infrastructure to support growth, optimize operations, or improve services. For instance, in November 2024, Sanofi S.A., a France-based pharmaceutical company, inaugurated a $596 million modular manufacturing facility in Singapore's Tuas Biomedical Park. This state-of-the-art facility is designed to produce various vaccines and biopharmaceuticals simultaneously, leveraging advanced technologies and environmentally friendly initiatives. This new site expands Sanofi's capacity to address future health challenges and expedite the delivery of vital treatments.

Regional Insights

Europe was the largest region in the hexyon market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Hexyon Market?

The hexyon market consists of sales of dupilumab, insulin glargine, agalsidase beta, and others. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Hexyon Market Report 2026?

The hexyon market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the hexyon industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.